MONTREAL, March 20, 2006 (PRIMEZONE) -- Viropro Inc. ("Viropro" or "The Company") (OTCBB:VPROE) sought to clarify the status of its SEC requisite filings that have been delayed due to recent changes.
Dr. Jean-Marie Dupuy, Chief Executive Officer of Viropro Inc., stated, "Since the management change, my official nomination on November 19, 2005 as well as our office move in October 2005, Viropro has realigned its business model and adopted business development objectives focused on the international markets." He added: "These important changes have made possible the consolidation of the Company's assets and brought concrete results within the framework of our business operations, but in so doing, have caused us to miss our filing deadline."
The Company has been assured by its U.S. auditors that the audit is expected to be completed, and the deficiency corrected, fairly quickly. Viropro Inc. further assures its investors that it anticipates the ticker symbol's temporary change will not affect the Company's operations.
About Viropro Inc.
Viropro Inc. operates mainly through its subsidiary Viropro International Inc. with its Head Office in Montreal, Canada. Viropro is a company specialized in marketing its know how and expertise in technology transfer for industrial production of therapeutic proteins. Its primary objective is to assist pharmaceutical companies in regions of the globe with unmet medical needs such as South America, Asia and Africa. Viropro develops and sells therapeutic proteins at a competitive price. Beside today's announcement, Viropro has concluded other strategic alliances with renowned scientific and business partners, both at the national and international levels. Viropro relies on a business model built to generate short and medium term recurrent revenues while increasing the value of stock for both the company and its shareholders.
For more information on Viropro Inc, please visit our website at www.viropro.com.
Viropro Inc.'s Safe Harbor Statement
Except for any historic information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, which are subject to section 27A of the Securities Act of 1933 and section 21E of the Exchange Act of 1934, and are subject to safe harbour created by these sections. Any statements that express or involve discussions with respect to predictions, beliefs, plans, projections, objectives, goals, assumptions of future events or performances are not statements of historical fact and may be "forward-looking statements". Forward-looking statements in this release may be identified through the use of such words as "expects", "anticipates", "estimates", "believes", or statements indicating certain actions "may", "could", or "might" occur. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements, which involve numerous risks and uncertainties, including the Company's ability to market its products and services in a competitive environment as well as other factors.